⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NMRA News
Neumora Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
NMRA
Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026
globenewswire.com
NMRA
NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics (NMRA) for Potential Securities Fraud
businesswire.com
NMRA
NMRA Investor Alert: Levi & Korsinsky Investigates Neumora Therapeutics, Inc. (NMRA) for Potential Securities Fraud
accessnewswire.com
NMRA
NMRA SHAREHOLDER INVESTIGATION: SueWallSt Investigates Neumora Therapeutics for Possible Securities Law Violations
prnewswire.com
NMRA
Neumora Therapeutics Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics (NMRA)
prnewswire.com
NMRA
Neumora Therapeutics, Inc. Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Neumora Therapeutics, Inc. (NMRA)
accessnewswire.com
NMRA
NMRA INVESTOR ALERT: Holzer & Holzer, LLC Investigation of Neumora Therapeutics, Inc.
globenewswire.com
NMRA
Form 8-K
sec.gov
NMRA
Neumora Therapeutics Reports Data from Phase 3 KOASTAL Program and Provides Business and Pipeline Update
globenewswire.com
NMRA